After a year of treatment with an experimental drug made by Aimmune Therapeutics, 67 percent of children and teenagers with peanut allergies were able to safely ingest the equivalent of at least two peanuts, compared with just 4 percent of those on placebo, according to the study published in the New England Journal of Medicine. (Ulysses Muñoz, Kim Hairston / Baltimore Sun video)